Novavax Inc. Stock Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) inched 0.60% higher to $16.64 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.58% to 11,049.50 and Dow Jones Industrial Average falling 1.45% to 33,849.46. Novavax Inc. closed $219.86 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.05% to $177.33, Pfizer Inc. (PFE) rose 0.73% to $49.57, and Merck & Co. Inc. (MRK) rose 0.88% to $108.45. Trading volume (3.4 M) remained 1.8 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 28, 2022.
(END) Dow Jones Newswires
November 28, 2022 17:23 ET (22:23 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.